Agios Pharmaceuticals | AGIO - 贷款资金



金融业
股票价格
USD
资产
USD 1.11B
现金及等价物
USD 99.65M
销售成本
USD 1.32M
流动资产
USD 717.67M
流动负债
USD 70.22M
债务
USD 35.75M
EBIT
USD -110.03M
EBITDA
USD -108.66M
员工
486
EPS每股收益
USD -1.69
股本和储备
USD 1.03B
销售毛利
USD 19.43M
债务利息支出
USD 1.11B
利息收入
USD 10.8M
贷款资金
USD 1.06M
市值
USD 2B
净收入
USD -99.11M
营业费用
USD 130.77M
营业利润
USD -110.03M
普通股股本
USD 59.34M
PE价格收益
3.56
税前利润
USD -99.11M
销售收入
USD 44.74M
销售和管理费用
USD 38.46M
股票
USD 35.75M
贸易债权人
USD 16.35M
应收帐款人
USD 16.13M


贷款资金 更改 日
AbbVie USD 64.53B 5.59B 2026-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
Amgen USD 51.86B 27M 2026-06
Arrowhead Research USD 824.07M 401.34M 2026-06
Astellas Pharma JPY 320B 0 2026-06
AstraZeneca USD 26.01B 46M 2026-06
Bayer EUR 31.16B 480M 2026-06
Biogen USD 7.29B 1B 2026-06
BioMarin Pharmaceutical USD 3.53B 2.1B 2026-06
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Daiichi Sankyo JPY 500B 199.92B 2026-06
Eli Lilly USD 47.86B 8.49B 2026-06
Gilead Sciences USD 20.86B 1.27B 2026-03
GlaxoSmithKline GBP 13.95B 65M 2026-06
Incyte USD 28.42M 994K 2026-06
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
Merck USD 51.08B 4.41B 2026-06
Moderna USD 597M 6M 2026-06
Nektar Therapeutics USD 60.27M 2.89M 2026-03
Novartis USD 37.49B 42M 2026-06
Novartis USD 37.45B 7.86B 2026-03
Pfizer USD 60.5B 70M 2026-06
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Sarepta Therapeutics USD 847.62M 9.46M 2026-06
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12